$AFCG
Advanced Flower Capital Inc. Stock $afcg

$afcg Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000182252324000037 Filed on August 07, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$8.882M	$18.38M	$16.10M
YoY Change	-41.84%	14.19%	-19.12%
Cost Of Revenue	$981.8K	$3.985M	$3.313M
YoY Change	-72.5%	20.27%	-21.14%
Gross Profit	$7.901M	$14.40M	$12.79M
YoY Change	-24.61%	12.62%	-18.57%
Gross Profit Margin	88.95%	78.32%	79.42%
Selling, General & Admin	$1.493M	$2.437M	$1.626M
YoY Change	-5.48%	49.88%	2.4%
% of Gross Profit	18.9%	16.93%	12.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.475M	$6.422M	$4.940M
YoY Change	-51.95%	30.02%	-14.68%
Operating Profit	$5.425M	$7.977M	$7.846M
YoY Change	1.81%	1.66%	-20.85%
Interest Expense	$1.573M	$1.573M	$1.576M
YoY Change	2.59%	-0.16%	-9.8%
% of Operating Profit	28.99%	19.72%	20.08%
Other Income/Expense, Net	-$181.4K	$6.190M	$1.606M
YoY Change	-82.73%	285.4%	-200.82%
Pretax Income	$1.604M	$16.73M	$12.30M
YoY Change	-81.44%	36.0%	6.83%
Income Tax	$386.3K	$286.0K	$200.0K
% Of Pretax Income	24.08%	1.71%	1.63%
Net Earnings	$1.384M	$16.45M	$12.14M
YoY Change	-82.66%	35.52%	6.9%
Net Earnings / Revenue	15.58%	89.46%	75.38%
Basic Earnings Per Share	$0.06	$0.80	$0.59
Diluted Earnings Per Share	$0.06	$0.80	$0.59
COMMON SHARES
Basic Shares Outstanding	20.67M shares	20.67M shares	20.46M shares
Diluted Shares Outstanding	20.79M shares	20.44M shares	20.32M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$122.2M	$170.3M	$82.08M
YoY Change	66.89%	107.48%	80.06%
Cash & Equivalents	$122.2M	$170.3M	$82.08M
Short-Term Investments
Other Short-Term Assets	$423.0K	$691.8K	$697.9K
YoY Change	-15.41%	-0.87%	12.57%
Inventory
Prepaid Expenses
Receivables	$0.00	$0.00
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$122.6M	$171.0M	$82.78M
YoY Change	66.33%	106.57%	79.16%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$244.0M	$287.0M	$371.2M
YoY Change	-34.29%	-22.68%	-10.14%
TOTAL ASSETS
Total Short-Term Assets	$122.6M	$171.0M	$82.78M
Total Long-Term Assets	$244.0M	$287.0M	$371.2M
Total Assets	$366.6M	$458.0M	$454.0M
YoY Change	-17.63%	0.88%	-1.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$658.2K	$1.436M	$1.284M
YoY Change	-17.72%	11.83%	30.14%
Accrued Expenses	$4.031M	$5.758M	$6.576M
YoY Change	-46.97%	-12.44%	-43.08%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$71.93M	$55.24M	$25.70M
YoY Change	295.22%	114.98%	8.58%
LONG-TERM LIABILITIES
Long-Term Debt	$88.46M	$88.31M	$87.71M
YoY Change	0.64%	0.68%	-9.41%
Other Long-Term Liabilities	$164.7K	$157.3K	$259.2K
YoY Change	-17.67%	-39.29%	-56.43%
Total Long-Term Liabilities	$88.63M	$88.47M	$87.97M
YoY Change	0.6%	0.56%	-9.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$71.93M	$55.24M	$25.70M
Total Long-Term Liabilities	$88.63M	$88.47M	$87.97M
Total Liabilities	$160.6M	$143.7M	$113.7M
YoY Change	51.0%	26.43%	-6.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$42.35M	-$36.51M	-$9.103M
YoY Change	287.03%	301.13%	481.42%
Common Stock	$218.8K	$206.7K	$204.6K
YoY Change	6.96%	1.02%	3.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$206.1M	$314.3M	$340.3M
YoY Change
Total Liabilities & Shareholders Equity	$366.6M	$458.0M	$454.0M
YoY Change	-17.63%	0.88%	-1.15%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	$1.384M	$16.45M	$12.14M
YoY Change	-82.66%	35.52%	6.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$2.644M	$10.32M	$5.146M
YoY Change	-51.58%	100.54%	-51.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$6.990M	$113.0M	$8.034M
YoY Change	54.65%	1305.95%	-142.12%
Cash From Investing Activities	-$6.990M	$113.0M	$8.034M
YoY Change	54.65%	1305.95%	-142.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-43.79M	-35.28M	-11.71M
YoY Change	345.9%	201.35%	23.0%
NET CHANGE
Cash From Operating Activities	2.644M	10.32M	5.146M
Cash From Investing Activities	-6.990M	113.0M	8.034M
Cash From Financing Activities	-43.79M	-35.28M	-11.71M
Net Change In Cash	-48.13M	88.00M	1.474M
YoY Change	442.05%	5871.54%	-108.17%
FREE CASH FLOW
Cash From Operating Activities	$2.644M	$10.32M	$5.146M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	888750	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	13020269	usd
CY2024Q2	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	157333	usd
CY2024Q2	us-gaap	Management Fee Payable ManagementFeePayable	3985028	usd
CY2024Q2	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	884310	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	1436061	usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	125	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20457697	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	204577	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	349805890	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29958243	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	320052225	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	466585055	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	17675188	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	36318581	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	36175674	usd
CY2023Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1575775	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3176438	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3243935	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16099413	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33142143	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32931739	usd
CY2023Q2	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	427581	usd
	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	588993	usd
	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	906225	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3313493	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7447790	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7017712	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1075873	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3082008	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	130769	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	912565	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	411347	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	419577	usd
	us-gaap	Professional Fees ProfessionalFees	1970776	usd
	us-gaap	Professional Fees ProfessionalFees	840475	usd
	us-gaap	Operating Expenses OperatingExpenses	12437337	usd
	us-gaap	Operating Expenses OperatingExpenses	11351542	usd
CY2023Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-1606187	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-1258566	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-903761	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-93338	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-26384	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-462918	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-5033694	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1940609	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12302970	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16836340	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22503346	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	167637	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	444335	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	342739	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	12135333	usd
	us-gaap	Net Income Loss NetIncomeLoss	16392005	usd
	us-gaap	Net Income Loss NetIncomeLoss	22160607	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20317341	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20396940	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20310606	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20322857	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20381724	shares
CY2024Q2	afcg	Loans Held For Investment And Financing Receivable Before Allowance For Credit Loss LoansHeldForInvestmentAndFinancingReceivableBeforeAllowanceForCreditLoss	275620392	usd
CY2024Q2	afcg	Interest Receivables InterestReceivables	1659502	usd
CY2023Q4	afcg	Interest Receivables InterestReceivables	2680188	usd
CY2023Q4	afcg	Payment In Kind Receivable PaymentInKindReceivable	1009974	usd
CY2024Q2	afcg	Unused Fees Receivable UnusedFeesReceivable	35116	usd
CY2023Q4	afcg	Unused Fees Receivable UnusedFeesReceivable	25833	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	1729188	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	3715995	usd
	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	0	loan
CY2023	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	0	loan
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	0	usd
CY2023Q2	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	600000	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	3600000	usd
CY2024Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1690334	usd
CY2023Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3200944	usd
CY2024Q2	afcg	New Reserves Interest NewReservesInterest	0	usd
CY2023Q2	afcg	New Reserves Interest NewReservesInterest	0	usd
	afcg	New Reserves Interest NewReservesInterest	0	usd
	afcg	New Reserves Interest NewReservesInterest	1526065	usd
CY2023Q2	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	559793	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	0	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	3596468	usd
CY2024Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	usd
CY2023Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1130541	usd
CY2024Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	usd
CY2023Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1130541	usd
CY2022Q2	afcg	Line Of Credit Facility Accordion Feature Increase Limit LineOfCreditFacilityAccordionFeatureIncreaseLimit	100000000.0	usd
CY2024Q2	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	49618382	usd
CY2024Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	34661390	usd
CY2024Q2	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	273580334	usd
CY2024Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
CY2024Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	25009024	usd
CY2024Q2	us-gaap	Notes Receivable Net NotesReceivableNet	250611368	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170298050	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	691787	usd
CY2024Q2	us-gaap	Assets Assets	457991783	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	894000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	16437	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	9819695	usd
CY2023Q4	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	115473	usd
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	3471726	usd
CY2023Q4	us-gaap	Senior Notes SeniorNotes	88014558	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	42000000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	146532830	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20667094	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20457697	shares
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2106206	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	4939712	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1986381	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20418897	shares
CY2023Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	314376929	usd
CY2024Q2	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	88091183	usd
CY2024Q2	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	28074169	usd
CY2024Q2	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	59329569	usd
CY2024Q2	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	98085413	usd
CY2024Q2	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	0	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	243276	usd
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	AFCG
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20667094	shares
CY2023Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	71644003	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2023Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	301265398	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	26309450	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	276996006	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	121626453	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1837450	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	1729188	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	3715995	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	688446	usd
CY2023Q4	us-gaap	Assets Assets	466585055	usd
CY2024Q2	us-gaap	Other Liabilities OtherLiabilities	24490	usd
CY2023Q4	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1486256	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	714685	usd
CY2024Q2	us-gaap	Senior Notes SeniorNotes	88311721	usd
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	35000000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	206671	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	350591362	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36514212	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	314283821	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	457991783	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	19957521	usd
CY2023Q1	afcg	Severance Costs Period To Receive Base Salary SeveranceCostsPeriodToReceiveBaseSalary	P12M
CY2023Q1	afcg	Severance Cobra Premiums Paid Period SeveranceCOBRAPremiumsPaidPeriod	P12M
CY2023Q1	afcg	Share Based Compensation Arrangement By Share Based Payment Award Expiration Period Extension ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriodExtension	P1Y
CY2024Q2	us-gaap	Liabilities Liabilities	143707962	usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20667094	shares
CY2024Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1573275	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18384246	usd
CY2024Q2	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	214190	usd
CY2024Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3985028	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1053810	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	369343	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	1014208	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	6422389	usd
CY2024Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-6190240	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1420001	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16732096	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	285975	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	16446121	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20400004	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20437799	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	310621126	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	369343	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.63
CY2024Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	13020269	usd
CY2024Q2	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
CY2024Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
CY2024Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	125000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	16446121	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	314283821	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	337879330	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	130769	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.48
CY2023Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	9819695	usd
CY2023Q2	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
CY2023Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	12135333	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	340318237	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	320052225	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	912565	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.11
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	22940474	usd
	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	125000	usd
	us-gaap	Net Income Loss NetIncomeLoss	16392005	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	399427	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.04
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	21293666	usd
	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
	us-gaap	Net Income Loss NetIncomeLoss	22160607	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	340318237	usd
	us-gaap	Net Income Loss NetIncomeLoss	16392005	usd
	us-gaap	Net Income Loss NetIncomeLoss	22160607	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-1258566	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-903761	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-93338	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-26384	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1986381	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-5033694	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1940609	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	5313879	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2496655	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	912565	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	399427	usd
	afcg	Payment In Kind Interest PaymentInKindInterest	2351851	usd
	afcg	Payment In Kind Interest PaymentInKindInterest	8109786	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-55	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-1991747	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-2652172	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-50903	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	145996	usd
	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	0	usd
	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	3570403	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-5250	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-147500	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	513302	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-578241	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-601946	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-600983	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	729429	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	448783	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16692097	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9528462	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	90087162	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	16796204	usd
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	96061029	usd
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	21312827	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	53103033	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	18509287	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	59076900	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	23025910	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	225000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	225000	usd
	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	125000	usd
	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	95000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	102000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	60000000	usd
	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	19747400	usd
	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	22885311	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	usd
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	7737500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-27097400	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-90847811	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	48671597	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-58293439	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121626453	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140372841	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	170298050	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82079402	usd
	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	0	usd
	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	1500000	usd
	us-gaap	Notes Issued1 NotesIssued1	14672640	usd
	us-gaap	Notes Issued1 NotesIssued1	0	usd
	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	2423357	usd
	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	2610000	usd
	afcg	Securities Purchases Incurred But Not Yet Paid SecuritiesPurchasesIncurredButNotYetPaid	0	usd
	afcg	Securities Purchases Incurred But Not Yet Paid SecuritiesPurchasesIncurredButNotYetPaid	7995934	usd
	afcg	Dividends Declared But Not Yet Paid DividendsDeclaredButNotYetPaid	13020269	usd
	afcg	Dividends Declared But Not Yet Paid DividendsDeclaredButNotYetPaid	9819695	usd
	us-gaap	Interest Paid Net InterestPaidNet	2675138	usd
	us-gaap	Interest Paid Net InterestPaidNet	2951250	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	567070	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	415359	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses (“CECL”).</span></div>
	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	1	loan
CY2023	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	2	loan
CY2024Q2	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	77800000	usd
CY2023Q4	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	94200000	usd
CY2024Q2	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	49700000	usd
CY2023Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	71900000	usd
	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue	4000000.0	usd
	afcg	Proceeds From Sale Of Loans Held For Investment At Fair Value ProceedsFromSaleOfLoansHeldForInvestmentAtFairValue	19300000	usd
CY2024Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	34661390	usd
CY2024Q2	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	49618382	usd
CY2024Q2	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	49729397	usd
	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P0Y
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2023Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	71644003	usd
CY2023Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	71883402	usd
CY2023	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P0Y4M24D
CY2023Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	71883402	usd
CY2023Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	239399	usd
CY2023Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	-9923298	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-5033694	usd
	afcg	Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-5033694	usd
	afcg	Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount	128384	usd
	afcg	Loans Held For Investment At Fair Value Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount	128384	usd
	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value Outstanding Principal ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValueOutstandingPrincipal	4003945	usd
	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue	4003945	usd
	afcg	Proceeds From Sale Of Loans Held For Investment At Fair Value Outstanding Principal ProceedsFromSaleOfLoansHeldForInvestmentAtFairValueOutstandingPrincipal	19284846	usd
	afcg	Proceeds From Sale Of Loans Held For Investment At Fair Value ProceedsFromSaleOfLoansHeldForInvestmentAtFairValue	19284846	usd
	afcg	Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest	1134786	usd
	afcg	Loans Held For Investment At Fair Value Payment In Kind Interest LoansHeldForInvestmentAtFairValuePaymentInKindInterest	1134786	usd
CY2024Q2	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	49729397	usd
CY2024Q2	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	111015	usd
CY2024Q2	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	-14956992	usd
CY2024Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	34661390	usd
CY2024Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	34661390	usd
CY2024Q2	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	49618382	usd
CY2024Q2	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	49729397	usd
	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	12	loan
CY2023	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	9	loan
CY2024Q2	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	311100000	usd
CY2023Q4	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	333100000	usd
CY2024Q2	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	283700000	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	314400000	usd
	afcg	Loans Held For Investment At Carrying Value Outstanding Principal New Fundings LoansHeldForInvestmentAtCarryingValueOutstandingPrincipalNewFundings	107200000	usd
	afcg	Receivable With Imputed Interest Loan Repayments And Amortization Payments ReceivableWithImputedInterestLoanRepaymentsAndAmortizationPayments	49100000	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	90000000.0	usd
CY2024Q2	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.44
CY2023Q4	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.84
CY2024Q2	afcg	Loans Held For Investment Interest Rate Floor LoansHeldForInvestmentInterestRateFloor	0.037
CY2024Q2	afcg	Loans Held For Investment Quoted Interest Rate LoansHeldForInvestmentQuotedInterestRate	0.053
CY2024Q2	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	283678065	usd
CY2024Q2	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	10097731	usd
CY2024Q2	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	273580334	usd
	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P2Y1M6D
CY2023Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	314376929	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13111531	usd
CY2023Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	301265398	usd
CY2023	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P2Y2M12D
CY2023Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13111531	usd
CY2023Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	301265398	usd
	afcg	Receivable With Imputed Interest New Funding Face Amount ReceivableWithImputedInterestNewFundingFaceAmount	107183159	usd
	afcg	Receivable With Imputed Interest Discount On New Funding ReceivableWithImputedInterestDiscountOnNewFunding	2423357	usd
	afcg	Receivable With Imputed Interest New Funding Net Amount ReceivableWithImputedInterestNewFundingNetAmount	104759802	usd
	afcg	Receivable With Accretion Of Original Issue Discount Premium ReceivableWithAccretionOfOriginalIssueDiscountPremium	5185495	usd
	afcg	Accretion Of Original Issue Discount Net Amount AccretionOfOriginalIssueDiscountNetAmount	5185495	usd
	afcg	Receivable With Imputed Interest Loan Repayments Face Amount ReceivableWithImputedInterestLoanRepaymentsFaceAmount	46879654	usd
	afcg	Receivable With Imputed Interest Loan Repayments ReceivableWithImputedInterestLoanRepayments	46879654	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	90000000	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Original Issue Discount ReceivableWithImputedInterestSaleOfLoansOriginalIssueDiscount	251662	usd
	afcg	Receivable With Sale Of Loans Net Amount ReceivableWithSaleOfLoansNetAmount	89748338	usd
	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	1217065	usd
	afcg	Receivable With Paid In Kind Interest Net Amount ReceivableWithPaidInKindInterestNetAmount	1217065	usd
	afcg	Receivable With Imputed Interest Amortization Payments ReceivableWithImputedInterestAmortizationPayments	2219434	usd
	afcg	Receivable With Imputed Interest Loan Amortization Payments ReceivableWithImputedInterestLoanAmortizationPayments	2219434	usd
CY2024Q2	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	283678065	usd
CY2024Q2	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	10097731	usd
CY2024Q2	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	273580334	usd
CY2024Q2	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	283678065	usd
CY2024Q2	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	10097731	usd
CY2024Q2	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	273580334	usd
CY2023Q4	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2024Q2	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2024Q2	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000.0	usd
CY2023Q4	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000.0	usd
CY2023Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2000000.0	usd
CY2024Q2	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2000000.0	usd
CY2023Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2041744	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1686	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	usd
	afcg	Payments On Loans Receivable Carrying Value PaymentsOnLoansReceivableCarryingValue	0	usd
CY2024Q2	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2041744	usd
CY2024Q2	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1686	usd
CY2024Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
CY2024Q2	us-gaap	Financing Receivable Originated Four Years Before Latest Fiscal Year FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear	2040058	usd
CY2024Q2	afcg	Payment In Kind Receivable PaymentInKindReceivable	34570	usd
CY2024Q2	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	0	usd
CY2024Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1320000	usd
CY2024Q2	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	0	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	253275	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	1573275	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1293750	usd
CY2023Q2	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	38749	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	1575775	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	2669887	usd
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	0	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	506551	usd
	us-gaap	Interest Expense InterestExpense	3176438	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	2729167	usd
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	74582	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	440186	usd
	us-gaap	Interest Expense InterestExpense	3243935	usd
CY2024Q2	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	392900838	usd
CY2023Q4	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	431239913	usd
CY2024Q2	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	375102310	usd
CY2023Q4	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	421239913	usd
CY2024Q2	us-gaap	Contractual Obligation ContractualObligation	17798528	usd
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	10000000	usd
CY2023Q1	afcg	Severance Cobra Premiums Paid Percentage SeveranceCOBRAPremiumsPaidPercentage	1
CY2023Q1	afcg	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Vesting Number Of Tranches ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingNumberOfTranches	1	tranche
	us-gaap	Severance Costs1 SeveranceCosts1	0	usd
	us-gaap	Severance Costs1 SeveranceCosts1	700000	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q2	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	20000000	usd
CY2023	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2024Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	161879	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	206304	shares
CY2024Q2	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares	2212753	shares
CY2023Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares	2168328	shares
CY2024Q2	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative	5511	shares
CY2023Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative	5511	shares
CY2024Q2	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares	200169	shares
CY2023Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares	200169	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	900000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	100000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.74
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.74
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M7D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2123596	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	17.72
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M3D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2800000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M20D
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	16446121	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	12135333	usd
	us-gaap	Net Income Loss NetIncomeLoss	16392005	usd
	us-gaap	Net Income Loss NetIncomeLoss	22160607	usd
CY2024Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7500	usd
CY2023Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7500	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7500	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	7500	usd
CY2024Q2	us-gaap	Dividends Dividends	128270	usd
CY2023Q2	us-gaap	Dividends Dividends	103805	usd
	us-gaap	Dividends Dividends	185396	usd
	us-gaap	Dividends Dividends	139277	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	16310351	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16310351	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	12024028	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12024028	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16199109	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	16199109	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	22013830	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	22013830	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20400004	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20317341	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20396940	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20310606	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	37795	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5516	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	21957	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	71118	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20437799	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20322857	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20418897	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20381724	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2206907	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2206907	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2417817	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2369907	shares
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
CY2024Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	285975	usd
CY2023Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	167637	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	444335	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	342469	usd
CY2024Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	0	usd
CY2023Q2	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	0	usd
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	0	usd
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	270	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	285975	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	167637	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	444335	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	342739	usd
CY2024Q2	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	183000.0	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	288300	usd
CY2024Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	103000.0	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	156000.0	usd
CY2023Q2	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	131500	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	263000.0	usd
CY2023Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	36100	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	79500	usd
CY2024Q2	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	afcg	Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains	0.04
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	34661390	usd
CY2024Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	34661390	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	61720705	usd
CY2024Q2	afcg	Incentive Compensation IncentiveCompensation	2900000	usd
	afcg	Incentive Compensation IncentiveCompensation	5300000	usd
CY2023Q2	afcg	Incentive Compensation IncentiveCompensation	2400000	usd
	afcg	Incentive Compensation IncentiveCompensation	5200000	usd
CY2024Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	4734972	usd
CY2023Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	4210695	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	8980053	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	9000941	usd

Files In Submission

Name	View Source	Status
0001822523-24-000037-index-headers.html	Edgar Link	pending
0001822523-24-000037-index.html	Edgar Link	pending
0001822523-24-000037.txt	Edgar Link	pending
0001822523-24-000037-xbrl.zip	Edgar Link	pending
afcg-20240630.htm	Edgar Link	pending
afcg-20240630.xsd	Edgar Link	pending
afcg-20240630xex311.htm	Edgar Link	pending
afcg-20240630xex312.htm	Edgar Link	pending
afcg-20240630xex321.htm	Edgar Link	pending
afcg-20240630xex322.htm	Edgar Link	pending
afcg-20240630_g1.jpg	Edgar Link	pending
amendmentnumbertwotocredit.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
afcg-20240630_def.xml	Edgar Link	unprocessable
afcg-20240630_lab.xml	Edgar Link	unprocessable
afcg-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
afcg-20240630_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
afcg-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AFCG
Advanced Flower Capital Inc. Stock $afcg

2024 Q3 Form 10-Q Financial Statement

#000182252324000037 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG Advanced Flower Capital Inc. Stock $afcg

2024 Q3 Form 10-Q Financial Statement

#000182252324000037 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG
Advanced Flower Capital Inc. Stock $afcg